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ABSTRACT: The packaging of proteins into discrete
compartments is an essential feature for cellular efficiency.
Inspired by Nature, we harness virus-like assemblies as artificial
nanocompartments for enzyme-catalyzed cascade reactions.
Using the negative charges of nucleic acid tags, we develop a
versatile strategy to promote an efficient noncovalent co-
encapsulation of enzymes within a single protein cage of
cowpea chlorotic mottle virus (CCMV) at neutral pH. The
encapsulation results in stable 21−22 nm sized CCMV-like
particles, which is characteristic of an icosahedral T = 1
symmetry. Cryo-EM reconstruction was used to demonstrate the structure of T = 1 assemblies templated by biological soft
materials as well as the extra-swelling capacity of these T = 1 capsids. Furthermore, the specific sequence of the DNA tag is
capable of operating as a secondary biocatalyst as well as bridging two enzymes for co-encapsulation in a single capsid while
maintaining their enzymatic activity. Using CCMV-like particles to mimic nanocompartments can provide valuable insight on the
role of biological compartments in enhancing metabolic efficiency.
■ INTRODUCTION
In recent years, there is increasing evidence to suggest that
prokaryotes adopt primitive organelle-like structures called
bacterial microcompartments or nanocompartments, depend-
ing on their size. Such assemblies localize and compartmen-
talize multiple enzymes and substrates involved in specific
metabolic pathways.1 The ability to mimic and understand
enzymatic activity in confinement would provide ground-
breaking insight into these assemblies and in organelles in
general.2
One of the main challenges is to controllably package and
coencapsulate different enzymes noncovalently within the same
compartment as exemplified by Nature. There has been some
success using coiled-coil helices,3 peptide tags,4 and protein−
protein fusion constructs5 to direct enzymatic cargo encapsu-
lation into protein cages. However, such approaches often lead
to covalently connected protein cargo or inefficient loading
(i.e., formation of empty cage assemblies). To circumvent these
problems, we seek a versatile approach that would promote a
noncovalent co-encapsulation of enzymes within a single
protein cage in vitro.
The cowpea chlorotic mottle virus (CCMV) is an ideal
candidate to mimic bacterial nanocompartments, owing to its
size and biocompatibility. The CCMV capsid is 28 nm in
diameter and is based on a T = 3 lattice (T, triangulation
number), with 12 pentamers and 20 hexamers of identical
monomers of capsid protein (CP) organized as 90 dimers.6
Similar to bacterial compartments,1c it has multiple pores in the
capsid shell (around 2 nm),7 which allows molecules and
substrates to diffuse in and out. The CP N-terminal region is
enriched in positively charged residues, termed the arginine-
rich motif (ARM), that face the capsid inner surface. After
removal of native single-strand (ss) RNA cargo, the ARM can
trigger reassembly of capsid protein dimers in the presence of
an appropriate negatively charged template, resulting in the
formation of monodisperse virus-like particles (VLP).3,8
Encapsulation of enzymes in VLPs has been shown to stabilize
and protect the enzymes, and its ease of modification enables
new applications.2d
In this contribution, single- and complementary-stranded
DNA tags are chemically attached to the exterior of chosen
enzymes, resulting in negatively charged complexes that induce
the co-encapsulation inside CCMV capsids. Unlike covalent
interactions, electrostatic interactions between the DNA tags
and the interior of the capsid provide a tunable system, enabled,
for instance, by changing the salt concentration or by varying
the length of the DNA chains. Hence, this makes our system a
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model for natural bacterial compartments (e.g., the encapsu-
lins) where the confined enzymes are not covalently bound but
rather included in the protein cage by noncovalent, multivalent
interactions.2e Noncovalent encapsulation mediated by nucleic
acid tags has been reported with the use of genetic engineering9
and/or only focused on a single enzyme.10 Using this strategy,
we were able to confine two separate cascade systems in vitro,
for which the glucose oxidase (GOx), a 160 kDa dimeric
enzyme, is chosen as the primary enzyme for both encapsulated
cascades.11 GOx catalyzes the oxidation of glucose into
gluconolactone (which undergoes spontaneous hydrolysis into
gluconic acid)12 and produces hydrogen peroxide as the side
product.11
In the first cascade system, hydrogen peroxide produced by
GOx is consumed by the so-called DNAzyme, a peroxidase-
mimic formed in situ by a specific sequence of ssDNA in the
presence of hemin (Figure 1A).13 In the second cascade system,
in the presence of ATP and NADP+, gluconic acid produced by
GOx is consumed by a secondary enzyme, gluconokinase
(GCK) that is coencapsulated inside the CCMV-like particles,
followed by a nonencapsulated tertiary enzyme, 6-phospho-
gluconate dehydrogenase (6-PGDH), to form ribulose-5-
phosphate and NADPH,14 the latter of which can be monitored
spectroscopically (Figure 1B). Therefore, the nucleic acid tags
in this work are useful both as a secondary biocatalyst (in
cascade system I) and as negatively charged tags to trigger the
encapsulation of the enzyme(s) (in cascade systems I and II).
■ RESULTS AND DISCUSSION
Encapsulation of Enzymes Promoted by DNA Anchor.
We anticipated that functionalization and subsequent hybrid-
ization of GOx and GCK with (complementary) single-
stranded DNA strands should promote their co-encapsulation
into CCMV capsids (Figure 2). We suspect that the size of the
enzyme cargo as well as the number and spatial distribution of
negative charges anchored to the enzyme surface might play a
role in determining the efficiency of the encapsulation. To
modify and hybridize the relevant enzymes, the lysine residues
of GOx and GCK were functionalized with a heterobifunctional
linker using sulfo-NHS coupling followed by maleimide−thiol
chemistry on the single stranded DNA (ssDNA) or its
complementary sequence (csDNA), respectively (see Figures
S1 and S2). All hybridized complexes were purified initially by
spin-filtration to remove excess DNA. Furthermore, size-
exclusion chromatography (SEC) was used for the GOx−
GCK dual-enzyme complex to remove nonhybridized GCK and
GOx prior to encapsulation (Figure S3).
Encapsulation of GOx−ssDNA, GCK−csDNA, or hybridized
GOx−GCK in CCMV at pH 7.5 led to the formation of stable
capsid-like assemblies, which were purified by SEC (Figure
3A−D). The elution volume (12 mL), together with the
relative absorbance ratio (260 nm/280 nm) > 1, are
characteristic features of intact CCMV capsids containing
DNA-based cargo. Control experiments with no DNA tags (i.e.,
nonfunctionalized GOx and/or GCK) confirmed that enzymes
lacking ssDNA or csDNA cannot be encapsulated (Figure S4).
As anticipated, the DNA strands provide the required negative
charges for reassembly into virus-like particles. This further
ensures that no empty particles are obtained with this strategy
and that formed particles always contain a negatively charged
cargo.
The assembled CCMV-like particles were characterized by
negative staining transmission electron microscopy (TEM)
(Figure 3E−H)15 and dynamic light scattering (DLS, Figure
S5), showing spherical structures of around 20 nm in diameter.
The size of around 20 nm indicates the formation of T = 1
icosahedral symmetry that is composed of 60 identical capsid
subunits.16 Furthermore, co-encapsulation of GOx and GCK in
Figure 1. Schematic representation of the enzyme pathways (encapsulated processes shown in gray boxes). (A) Cascade reaction by GOx−
DNAzyme. GOx oxidizes glucose to gluconic acid and produces H2O2, which DNAzyme uses for subsequent reaction with ABTS inside CCMV
capsid. (B) Cascade reaction performed by co-encapsulated GOx and GCK. The conversion of glucose to D-gluconate-6-P occurs at the interior of
the CCMV capsids, whereas the conversion of D-gluconate-6-P into ribulose-5-P occurs at the exterior of the CCMV capsid catalyzed by tertiary
enzyme, 6-PGDH.
Figure 2. Encapsulation of different enzyme−DNA hybrids inside
CCMV capsids (gray) at pH 7.5. Encapsulation of (A) ssDNA in
yellow, (B) GOx, in blue, functionalized with ssDNA, (C) GCK, in
green, functionalized with the complementary ssDNA in red, (D) GOx
conjugated to GCK. The specific sequence of ssDNA is catalytically
active in the presence of hemin.
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a single particle was confirmed with SDS-PAGE and Western
blot analyses (Figures S6 and S7). Additionally, their
concentrations and relative ratios were estimated by gel
densitometry, which suggested a GOx/GCK/capsid protein
ratio of approximately 1:1.4:60. Since the capsid protein is
composed of 60 identical subunits, we estimate that only a
single GOx−ssDNA is confined inside CCMV-like particles for
cascade system I and a hybrid of 1 GOx−DNA and 1 or 2
GCK−csDNA is confined for cascade system II.
Cryo-EM Reconstruction of Enzyme-Filled Particles.
To confirm the assembly of CCMV-like particles with T = 1
icosahedral symmetry, we analyzed the GOx−ssDNA-loaded
CCMV-like particles with cryo-electron microscopy (cryo-EM)
to calculate their native three-dimensional reconstruction
(3DR) (Figure 4A). The sample contained particles with
spherical and elongated profiles as well as irregular assemblies
(Figure 4A, inset). Two-dimensional classification followed by a
three-dimensional classification using Relion software resulted
in two sizes of icosahedral capsids with T = 1 architecture.16c
Whereas class I capsids were 214 Å in diameter (Figure 4B),
class II capsids were 226 Å (Figure 4C).
Capsids I and II made up 50% of the total particles in the
sample (70% class I, 30% class II). Both capsids were built of 12
pentamers, with different compacting levels. The cryo-EM
images analyzed for processing are in fact snapshots of the
dynamic states of the sample; the ratio observed could be due
to displacement of dynamic equilibrium toward class I T = 1
capsids (70% class I, 30% class II). The two particle sizes might
Figure 3. Purification and characterization of enzyme-filled CCMV capsids. Size-exclusion chromatograms for CCMV containing (A) ssDNA, (B)
GOx−ssDNA, (C) GCK−csDNA, and (D) GOx−GCK, with monitoring at λ = 260 (red), 280 (blue), and 450 nm (black), for DNA, CCMV, and
flavin (GOx), respectively. The schematic cartoons above each peak represent the corresponding particles. Negatively stained transmission electron
microscopy of (E) ssDNA, (F) GOx−ssDNA, (G) GCK−csDNA, and (H) GOx−GCK encapsulated CCMV assemblies.
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be related to the reported dynamic swelling of the T = 3
CCMV native capsid, as the size difference of 5% involves a ∼7
Å outward radial expansion and widening of the pores, hinting
at possible structural breathing. In both T = 1 capsids, the
pentamer bases were strongly connected to the underlying
GOx−ssDNA cargo, although the capsid surface pores were
distinct. Whereas class I capsid pentamers barely left any space
between their lateral contacts, those of class II capsids were
clearly separated and left large pores, especially at the
icosahedral 2-fold axes (Figure 4B, C, arrows).
Docking of CCMV capsid protein (CP) dimer into the cryo-
EM density maps of GOx-ssDNA-loaded T = 1 VLP showed
major structural differences of the two classes (Figure 5A,B).
Connecting densities between pentamers and cargo were
mediated by residues 42−50 of the CP N-terminal region
(Figure 5C, dark blue), although the preceding region (residues
27−41) could also be involved (Figure 5C, pink). The CP C-
terminal ends were responsible for CP dimer assembly in class I
CCMV T = 1 capsids (Figure 5A, arrows; Figure 5D, red). The
hinge angle formed between CP dimers in GOx−ssDNA-
loaded T = 1 class I capsids was ∼60° (Figure 5D); it resembles
that found at the quasi-2-fold axes of the swollen T = 3 CCMV
capsid17 and in other CP dimers such as the phthalocyanine-
loaded T = 1 VLP.18 CCMV CP dimers are the building blocks
of native T = 3 virion capsids as well as of in vitro assembled
structures such as tubes19 and icosahedral capsids with T = 1
(containing 30 CP dimers), T = 2 (60 dimers), and T = 3 (90
dimers) architecture.20 The outward expansion of the class II
capsid pentamer entailed the disappearance of or a great
reduction in dimeric contacts (Figure 5B, arrows) and indicated
that these interactions contribute much less to class II capsid
stability than to that of class I capsids. Assuming the same
building block is involved, the class II capsids are based on
pentamers bound weakly by the CP C-terminal ends (Figure
5E, red), which adhere strongly to the polyanionic cargo.
After imposing icosahedral symmetry in class I and II capsids,
we observed the packed cargo as a hollow sphere (9.6 × 105
and 1.2 × 106 Å3, respectively), with numerous connections to
the T = 1 capsid inner surface. A significant difference in cargo
packing between these two classes is therefore unlikely. Based
Figure 4. Three-dimensional cryo-EM reconstructions of GOx−ssDNA-loaded CCMV capsids. (A) Cryo-electron micrograph of GOx−ssDNA-
loaded CCMV capsids. Black arrows indicate elongated particles, and red arrowheads indicate irregular particles. Two-dimensional class averages
derived from the final 15481 particle data set (inset). Bar, 50 nm. (B) Surface-shaded representation of the outer surface of the class I T = 1 capsid
(diameter 21.4 nm) viewed along a 2-, 3-, and 5-fold axis of icosahedral symmetry (top to bottom). Models of the class I T = 1 capsid, with the front
half of the cargo and protein shell removed (right). Protein shell is white, cargo is yellow. Arrow indicates a 2-fold axis of icosahedral symmetry. (C)
Surface-shaded representations of the outer surface of the class II T = 1 capsid (diameter 22.6 nm) (as in B).
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on the atomic model of GOx (PDB 1GAL), several copies of
GOx could be encapsulated in the capsid, although our
biochemical analyses indicated the presence of a GOx dimer
only. This discrepancy is probably due to the chemical
modification of accessible Lys residues of GOx that are
covalently bound to ssDNA. The cargo−capsid connections
observed in the 3D cryo-EM maps probably represent the
interaction of the ARM region with negatively charged DNA
strands. GOx−ssDNA packaging resulted in a slightly
disordered icosahedral capsid (also reflected in a limited map
resolution), but this cargo enabled structural polymorphism
with weak CP interactions in the dimer. Both T = 1 capsids
coexist in dynamic equilibrium, probably enabled because the
CP−ssDNA interactions are more flexible (or less well-defined)
than the CP−ssRNA interactions. To our knowledge, this is the
first demonstration of the formation of a T = 1 CCMV-like
structure templated by a biological soft material that also
displays an extreme capsid swelling.
Confined Catalysis by Enzymatic Pathways. Following
structural characterization of enzyme−DNA complexes inside
T = 1 CCMV-like particles, we proceeded to monitor the
enzymatic activity of both cascade systems to examine whether
the encapsulated complexes were still catalytically active. For
cascade system I (Figure 1A and Figure 6A), we deliberately
chose the ssDNA sequence coupled to the GOx to be that of a
hemin-binding DNA quadruplex, the so-called DNAzyme. In
the presence of hemin, the ssDNA spontaneously forms a
scaffold that mimics the catalytic properties of horseradish
peroxidase (HRP).13 The catalytic activity of GOx−DNAzyme
was monitored via the production of ABTS+• at λ = 410 nm
upon addition of glucose to the system.21 The activity plot
obtained for encapsulated GOx−DNAzyme shows that both
GOx and DNAzyme remained catalytically active after
encapsulation (Figure 6B and Figure S8A). Furthermore,
both systems displayed catalytic activity profiles that seem to
follow Michaelis−Menten kinetics.22 An increase in both Km
values (2.2-fold) and kcat values (1.7-fold) is observed when the
system is encapsulated (summarized in Table S1).
For cascade system II consisting of GOx, GCK, and 6-PGDH
(Figure 1B), we monitored the formation of the end product,
NADPH at λ = 340 nm, upon addition of glucose to the
system.14 Both enzymes (GOx and GCK) are therefore
required for the reaction and its visualization at 340 nm. The
activity profile in Figure 6C and Figure S8B confirms that both
enzymes were present in the system and still active upon
hybridization and subsequent encapsulation. Comparable to
system I, the catalytic profiles of both systems also follow
Michaelis−Menten kinetics. While the Km values remain similar
for both systems, the kcat values show a 2-fold increase for the
encapsulated system (summarized in Table S1).
Based on the recurring trends, a slightly higher turnover
number (kcat) upon pathway encapsulation is estimated,
although the protein concentration determination by gel
densitometry is expected to have a large deviation and
consequently also the kcat. An eventual increase might be the
result of a local enhancement in effective molarity due to
confinement23 or of the channeling effect when multiple
enzymes in a cascade pathway are brought to a close proximity
inside a confined system.5a
The enzymatic activities observed for both cascade pathways
indicated that the substrate glucose was able to diffuse into the
capsid shell. We further investigated whether the intermediate
of the cascade could also diffuse freely or was trapped inside the
cagelike structure during the reaction. In order to confirm the
state of the intermediate, we added a catalase enzyme to the
bulk solution of encapsulated GOx−DNAzyme (Figure 6A). In
a competitive pathway, H2O2 is broken down to water and
oxygen by the enzyme catalase, and it can therefore act as an
external competitor with the DNAzyme.24 In contrast, if the
H2O2 intermediate is trapped inside CCMV (as proposed for
the bacterial microcompartments),25 the kinetics of ABTS•+
production should remain unaltered. Instead, we observed
almost complete suppression of ABTS•+ production in the
presence of catalase (Figure 6D). Only upon lowering the
buffer to pH 4 and hence inactivating catalase (t = 60 min)
could the H2O2 conversion by DNAzyme be restored while
maintaining the stability of the particles, as confirmed by SEC
and TEM analyses in Figure S9. This strongly suggested that
H2O2 can diffuse out of the CCMV capsid. Taken together, in
agreement with a previous report,26 we also observed that the
CCMV capsid shell is permeable to small molecules such as
H2O2, which can diffuse out of the capsid shell and react with
the competing enzyme. Nevertheless, it should be noted that
the DNAzyme is likely to exhibit lower catalytic efficiency and
lower affinity to H2O2 compared to catalase,
27 which could also
lead to the diffusion of H2O2 out of the CCMV capsid.
■ CONCLUSIONS
We have presented a highly effective strategy of using single-
stranded DNA for the controlled noncovalent packing of
enzyme cascades in a single protein capsid assembly. To
Figure 5. Pseudoatomic model of GOx−ssDNA-loaded CCMV
capsids. (A) T = 1 class I capsid viewed down a 3-fold axis from
outside, with docked CCMV CP atomic coordinates. A pentamer is
depicted in dark blue. Arrows indicate three dimeric contacts. (B)
Class II T = 1 capsid viewed down a 3-fold axis from outside (as in B).
(C) Pentamer contacts with the cargo mediated by residues 42−50 in
the N-terminal region (dark blue, bottom view). The N-terminal
region residues 27−41 might also contribute to cargo−pentamer
contacts (pink). (D, E) CP dimers in class I (D) and class II T = 1
capsids (E). Side view (top), top view (bottom). The hinge dihedral
angle is indicated. CP monomers in the class II dimer are 6.5 Å further
apart than class I dimers (N-terminal 27−32 region is omitted).
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demonstrate the versatility of this strategy, two different
cascade systems based on glucose oxidase were assembled
inside the protein shell of CCMV at pH 7.5 and were both
shown to be catalytically active. This encapsulation strategy
resulted in icosahedral structures of approximately 20 nm,
which were further analyzed with 3D cryo-EM. The resulting
3D reconstruction provides the first-time demonstration of T =
1 structured assemblies of CCMV around a biological soft
matter template. In addition, an extra-swelling phenomenon
was indicated on the basis of the coexistence of two differently
sized particles of similar structure and origin. The method
presented for assembling virus-like particles can provide a
structural and functional basis to analyze bacterial protein
organelles and will further improve our understanding of their
containment properties and biochemical function.
■ EXPERIMENTAL SECTION
Materials. Chemicals were purchased from Sigma-Aldrich unless
stated otherwise. The ssDNA (5′-HS-(CH2)6-GGGTAGGGCGGG-
TTGGGTTTT-3′) and csDNA (5′-HS-(CH2)6-AAAACCCAAC-
CCGCCCTACCC-3′) oligonucleotide sequences were synthesized
by Eurofins MWG Operon. For the coupling of DNA to enzymes, the
bifunctional cross-linker sulfo-EMCS (N-[ε-maleimidocaproyloxy]
sulfosuccinimide ester) was purchased from Pierce. D-Gluconate/D-
glucono-δ-lactone assay kit was purchased from Megazyme and used
as provided. All other reagents were purchased from Sigma-Aldrich or
Fluka unless stated otherwise and were used without further
purification. A stock solution of hemin (5 mM) was prepared in
DMSO and stored in the dark at 4 °C. Glucose was dissolved in 50
mM Tris−HCl, 100 mM KCl buffer at pH 7.5. All reactions were
carried out at room temperature unless stated otherwise.
Encapsulation of ssDNA, GOx−ssDNA, csDNA−GCK, and
GOx−GCK in CCMV Virus-like Particles. CCMV was dialyzed
against assembly buffer (250 mM Tris−HCl, 500 mM NaCl, 50 mM
MgCl2, 1 mM DTT, pH 7.5) to obtain CCMV dimer coat proteins
(CCMV-CP) (500 μM). ssDNA, GOx−ssDNA, csDNA−GCK, and
GOx−GCK were buffer exchanged against Milli-Q water using
Amicon Ultra centrifugal filters (30 kDa or 10 kDa MWCO). For
the encapsulation, ssDNA, GOx−ssDNA, csDNA−GCK, and GOx−
GCK and CCMV−CP (in assembly buffer) were mixed in a 4:1 (v/v)
ratio and incubated for 2 h at 4 °C before purification by size-exclusion
chromatography (SEC) using a Superose 6 10/100 GL column,
eluting with 50 mM Tris−HCl, 100 mM NaCl, 10 mM MgCl2, 0.5
mM DTT at pH 7.5. Protein fractions were collected and analyzed by
SDS−PAGE, agarose gel, and Western blot analysis. For the complete
procedure, see theSI.
Transmission Electron Microscopy Analysis. Samples (5 μL)
were applied onto Formvar−carbon-coated grids. After 1 min, the
excess liquid was drained. Uranyl acetate (5 μL, 1% w/v) was added
and the excess liquid was drained after 20 s and dried for 30 min at
room temperature. The samples were examined on a FEG-TEM
(Phillips CM 30) operated at 300 kV acceleration voltages.
Cryo-electron Microscopy and Image Processing. GOx−
ssDNA-loaded VLP (5 μL) were applied to one side of Quantifoil R 2/
2 holey grids, blotted, and plunged into liquid ethane in a Leica EM
CPC cryofixation unit. The grids were analyzed in a Tecnai G2
electron microscope equipped with a field emission gun operating at
200 kV, and images were recorded under low-dose conditions with a
FEI Eagle CCD at a detector magnification of 69,444X (2.16 Å/pixel
sampling rate). Image processing operations were performed using
Xmipp28 and Relion,29 and graphic representations were produced
with UCSF Chimera.30 The Xmipp automatic picking routine was
used to select 15481 particles, and defocus was determined with
CTFfind.31 Images were 2D-classified using the appropriate Relion
routine and 7932 isometric particles were selected. The structure of
phthalocyanine-loaded CCMV T = 1 capsid18 was filtered out to 30 Å,
and the cargo density was masked. This map was used as an initial
model for 3D classification of spherical particles, using Relion to select
Figure 6. Enzymatic activity in CCMV confinement. (A) Schematic representation of cascade system I in the presence of a competing enzyme,
catalase (encapsulated processes shown in gray boxes). (B) Kinetic measurements of cascade system I; the production of ABTS•+ was monitored at λ
= 410 nm at different glucose concentrations. (C) Kinetic measurements of cascade system II; the production of NADPH was monitored at λ = 340
nm at different glucose concentrations. (D) Kinetic measurements for the production of ABTS+· in the presence of and after pH inactivation of the
competing enzyme, catalase.
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5572 (class I) and 2318 (class II) particles; these data sets were used
to obtain the final 3DRs using the Relion autorefinement routine.
Resolution was assessed by gold standard FSC between two
independently processed half-data sets. Applying a correlation limit
of 0.5 (0.3), the resolution for class I and II 3D maps was 22.7 (22.2)
and 25.6 (21.3) Å, respectively. The Chimera fitting tool was used to
dock the atomic structure of a whole pentamer from the X-ray
structure of CCMV17a (PDB entry 1CWP) into the cryoEM maps.
Kinetic Measurements of GOx−GCK: NADPH Assay. Substrate
solutions containing various glucose concentrations (0−1 M, 180 μL)
were prepared. An enzyme solution containing either (1) free GOx−
GCK (60 μL) or (2) encapsulated GOx−GCK (60 μL) was used in
these studies. 6-PGDH (55 U/mL, 2 μL) and 16.1 mM NADP+
containing 69.4 mM ATP were added to each reaction mixture at pH
7.5, according to the manufacturer’s instructions (Megazyme kit). The
reaction was started upon addition of glucose (120 μL) to enzyme (82
μL), and formation of reduced NADPH was monitored at λ = 340 nm
in 100 s time intervals over 2 h at 27 °C.
Kinetic Measurements of GOx−DNAzyme: ABTS Assay. Stock
solutions containing both substrates glucose (ranging from 0−1 M)
and 4 mM ABTS were freshly prepared at room temperature.
Individual solutions containing either (1) free GOx−DNAzyme (30
μL) and hemin (30 μL, 5 μM) or (2) encapsulated GOx−DNAzyme
(30 μL) and hemin (30 μL, 5 μM) were prepared and incubated at rt
for 2 h. To each enzyme containing solution (60 μL) was added the
substrate solution containing both glucose and ABTS (120 μL), and
the reaction was monitored immediately at λ = 410 nm for the
conversion of ABTS to ABTS•+ at 27 °C in 100 s time intervals over 2
h. Control experiments containing hemin, glucose, and ABTS were
performed under the same reaction conditions.
Data Analysis. Experimental data were corrected for background
absorbance (using the control experiment as a reference). The
concentration of ABTS•+ or NADPH was determined using the
Lambert−Beer law, assuming extinction coefficients of ABTS•+
(ε410 nm = 36000 M
−1 cm−1) or NADPH (ε340 nm = 6300 M
−1 cm−1)
before plotting concentration (μM) vs time (min) curves, from which
the velocity (v) was determined (μM/min). A dilution factor (DF)
relative to the enzyme (GOx) and a proportionality factor of ABTS to
substrate consumption (p = 1/2) were used to correct the velocity
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